A TGA review in 2020 recommended the adoption of a full notification system. Under the regulator's favoured option, early notification would have been required regardless of "the existence of a patent". It hasn't happened.
Next stop is a review of existing trade agreements, including Australia
April 6, 2025 Latest NewsBioPharma
Latest Video
New Stories
-
The 'Dispatched' Podcast - 'Week in Review' 11 April
April 11, 2025 - - Podcast -
Opthea updates investors, confirming significant staff reduction
April 10, 2025 - - Australian Biotech -
'From a patient point of view, we can provide more solutions to more health challenges'
April 10, 2025 - - Podcast -
Pharmac to fund wider access to medicines following bundle agreement with AbbVie
April 10, 2025 - - Latest News -
Icon Cancer Centre and Omico partner to expand access to precision oncology
April 10, 2025 - - Latest News -
President announces 90-day pause on higher tariffs, but pharma fate remains unclear
April 10, 2025 - - Latest News -
US report acknowledges China is now the leader in global biotechnology
April 10, 2025 - - Latest News